Minimus Spine, Inc. (www.minimusspine.com) announced that it recently received another Notice of Allowance from the United States Patent and Trademark Office. The patent covers Minimus Spine’s novel ozone syringe, which is intended to treat herniated spinal discs without surgery. “This is the second U.S. patent to be issued recently and adds to our growing patent
portfolio”, said David Hooper, PhD, Minimus Spine’s Founder and CEO. “With five issued US patents, we continue to build protection around our approach to creating, measuring and delivering ozone for spinal injection. While many physicians and patients are excited by the international medical literature, it is understood that improvements to the existing ozone solutions are needed for wider adoption by the medical community. Our system addresses the drawbacks of the currently available technology.”
About Minimus Spine:
Established in 2006, Minimus Spine is a privately held medical device company dedicated to developing its ozone technology for medical applications. The company is focused on the treatment of spinal disorders related to herniated discs. Minimus Spine is headquartered in Austin, TX. For more information on Minimus Spine, please visithttp://www.minimusspine.com or email info@minimusspine.com.
Minimus Spine ™ Announces Continued Progress with Patent Portfolio
(Visited 2 times, 2 visits today)